The company is significantly advanced its progress of a innovative treatment for ATTR-CM, leveraging the investigational drug. Initial patient results reveals significant benefits for those diagnosed by this debilitating illness. This focus underscores researchers’ focus to addressing unmet patient demands in a heart field. Attruby: Bri… Read More